RIVASTIGMINE vs ROMOSOZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RIVASTIGMINE vs ROMOSOZUMAB: Safety Overview
| Metric | RIVASTIGMINE | ROMOSOZUMAB |
|---|---|---|
| Total FAERS Reports | 9,123 | 434 |
| Deaths Reported | 2,232 | 48 |
| Death Rate | 24.5% | 11.1% |
| Hospitalizations | 2,716 | 81 |
| Average Patient Age | 80.0 yrs | 69.1 yrs |
| % Female Patients | 59.5% | 94.5% |
| FDA Approval Date | Apr 21, 2000 | N/A |
| Manufacturer | Novartis Pharmaceuticals Corporation | Amgen, Inc |
| Route | TRANSDERMAL | SUBCUTANEOUS |
| Marketing Status | Discontinued | N/A |